Vertex Pharmaceuticals (NasdaqGS:VRTX) announced that its cystic fibrosis treatment, ALYFTREK®, had received regulatory approval from the UK's MHRA, a significant milestone in expanding its market ...

If you’ve been to the doctor and received treatment, that treatment was very likely built on NIH-supported research.

Living with cystic fibrosis means constantly navigating the emotional and physical strain of waiting. Despite the exhaustion and uncertainty, waiting reminds us of our ability to endure in the face of ...

Genetic screening can be a game-changer for women’s health, enabling proactive steps in preventing and managing diseases like ...

95 percent of rare diseases, unlike cystic fibrosis, have no treatment ... “are essential for keeping research labs running.” For families of children with ultra-rare conditions, such as ...

Pilot columnist Patrice Apodaca speaks to a UC Irvine professor who worries limits to indirect funding at the NIH could ...

Up to 8 students will be accepted into this CF-focused, paid summer program, running from June 2 to July 25, 2025, to work with faculty affiliated with the UAB Gregory Fleming James Cystic Fibrosis ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

This was an alarming start to the idea of gene de-extinction. As we know from movies like The Thing, digging up frozen ...

As STAT’s Helen Branswell writes, mRNA vaccines are the fastest to make and the easiest to mass produce.

Stand Up for Science rallies in Washington, D.C., and across the United States drew crowds of people worried about cuts to scientific funding.